Clinical trials
Phase 1 Rhabdomyosarcoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2017 | 1 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 1 |
| Completed | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cellectar Biosciences, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| The Hospital for Sick Children | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rhabdomyosarcoma | 3 |
| Neuroblastoma | 2 |
| Sarcoma | 2 |
| Desmoplastic Small Round Cell Tumor | 1 |
| Diffuse Intrinsic Pontine Glioma | 1 |
| Ependymoma | 1 |
| Glioblastoma | 1 |
| Glioma | 1 |
| Gliosarcoma | 1 |
| Granuloma, Plasma Cell | 1 |
Trials
Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.